Skip to content
Home/Companies/MedTech/Lymphatica
Lymphatica

Lymphatica

MedTech·Switzerland·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Lymphatica?

Lymphatica is currently owned by High-Tech Gruenderfonds (HTGF) through HTGF III (2017 vintage), since 2020.

Hand-verified · updated 2026-08-11

High-Tech Gruenderfonds (HTGF)
Investor
High-Tech Gruenderfonds (HTGF)
HTGF III · 2017 · VC

Key facts

HQSwitzerland
SectorMedTech
StatusActive
Websitewww.lymphaticamedtech.com

More from HTGF III

Other portfolio companies in the same fund.

ActiTrexx
ActiTrexx
Active
BiotechGermany· 2021
Aegiq
Active
Deep TechUnited Kingdom· 2021
Altavo
Active
MedTechGermany· 2021
anybill
anybill
Active
FintechGermany· 2021
Argá Medtech
Argá Medtech
Active
MedTechSwitzerland· 2021
Avelios Medical
Avelios Medical
Active
HealthTechGermany· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Custom Surgical
Custom Surgical
Active
ZEISS VenturesGermany· 2026
Track Lymphatica

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Lymphatica.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue